Archive
Search

You can search published articles.

Journal Information

Online ISSN
1305-3124

Established
1993

Editors-in-Chief
​Cihat Şen, ​Nicola Volpe

Editors
Cecilia Villalain, Daniel Rolnik, M. Mar Gil

Managing Editors
Murat Yayla

Statistics Editor
Resul Arısoy

PP-040 Contribution of procalcitonin measured in umbilical cord blood in the management of asymptomatic early neonatal bacterial infections

Oussama Mghirbi, Myriam Barka, Sarra Becheur, Donia Brahem, Maha Taamli, Amani Khlifi, Sonia Merchaoui, Jihen ben Abdallah, manel Bellalah, Nabiha Mahdhaoui

Article info

PP-040 Contribution of procalcitonin measured in umbilical cord blood in the management of asymptomatic early neonatal bacterial infections. Perinatal Journal 2024;32(2024):33 DOI: 10.59215/prn.24.032supp040

Author(s) Information

Oussama Mghirbi1,
Myriam Barka1,
Sarra Becheur2,
Donia Brahem1,
Maha Taamli1,
Amani Khlifi1,
Sonia Merchaoui1,
Jihen ben Abdallah2,
manel Bellalah1,
Nabiha Mahdhaoui1

  1. Sousse University, Ibn El Jazzar Medical Faculty of Sousse, Department of Resuscitation and neonatal Medicine, University Hospital Center Farhat Hached, Sousse, Tunisia
  2. Sousse University, Ibn El Jazzar Medical Faculty of Sousse, Department of Biochemistry Laboratory, University Hospital Center Farhat Hached, Sousse, Tunisia
Correspondence

Oussama Mghirbi, Sousse University, Ibn El Jazzar Medical Faculty of Sousse, Department of Resuscitation and neonatal Medicine, University Hospital Center Farhat Hached, Sousse, Tunisia, [email protected]

Publication History

Manuscript Received: April 24, 2024

Manuscript Accepted: May 03, 2024

Publication date: May 18, 2024

Conflicts of Interest

No conflicts declared.

Objective
Early neonatal bacterial infection (ENBI) remains a major cause of perinatal morbidity and mortality. Any delay in initiating therapy can have a negative impact on prognosis. The search for an optimal early marker in terms of sensitivity and specificity is therefore a topical issue. The aim of our study is to evaluate the contribution of Procalcitonin (PCT) measured in umbilical cord blood in the early diagnosis and management of asymptomatic ENBI.
Methods
This is a prospective evaluative study conducted over a 12-month period. We included all asymptomatic newborns with risk factors for ENBI, born at the Maternity and Neonatology Center of the Farhat Hached Hospital in Sousse, Tunisia. We performed a PCT dosage on umbilical cord blood at birth with a positivity threshold set at 0.5 ng/ml. The newborns included were managed according to a well-established national algorithm for the management of newborns with suspected ENBI. Subsequently, regardless of the PCT value, newborns were classified into three groups: certain, probable, and refuted ENBI according to the algorithm's criteria. Newborns with a diagnosis of certain or probable infection were considered infected.
Results
During the study period, 9685 live births were recorded, and 1235 newborns were suspected of having ENBI, representing 12.7% of live births. The number of asymptomatic newborns at risk of ENBI was 599. Of these, 279 newborns were included in our study. ENBI was diagnosed in 20 cases, representing 1.61% of at-risk situations and 2.06 ‰ of live births. Chorioamnionitis was the only risk factor statistically correlated with ENBI (p=0.003). For a threshold value of 0.5 ng/mL, the sensitivity, specificity, positive predictive value, and negative predictive value of cord PCT were 55%, 96.5%, 55% and 96.5% respectively. The threshold value for PCT found by the receiver operating characteristic curve (ROC curve) was 0.415 ng/mL. For this threshold, we found a sensitivity of 60% and a specificity of 96.5%.
Conclusion
Our work demonstrates that the use of Procalcitonin (PCT) in umbilical cord blood can help in early diagnosing Early Neonatal Bacterial Infection (ENBI). Chorioamnionitis was also among the important factors. The diagnose threshold for PCT was found to be 0.415 ng/mL. More studies are needed to support these findings and enhance neonatal outcomes.
Keywords

newborn, bacterial infection, Procalcitonin